Hi! I'm Priya
I study cytokine immunotherapy for cancer, working at the intersection of molecular biology and translational health sciences. Currently pursuing my PhD at Nirma University under Prof Sarat Dalai, with 3+ years of prior biosimilars R&D experience at Sun Pharma.
I'm a cancer biologist driven by one question: can we teach the immune system to fight tumors more effectively? That curiosity has shaped my entire career, from the lab bench to the research podium.
My journey started with a Bachelor of Science at Pramukhswami Medical College, Karamsad, followed by a Master's in Biotechnology at Nirma University, where I graduated with an A+ grade. That foundation set the stage for everything that followed.
I spent over three years at Sun Pharma as a Senior Scientist in Biosimilars R&D, where I developed a clone for aflibercept and worked on bevacizumab, IL-23, and GLP-2 projects. The experience of building novel biologics from the ground up, from cell line development to process optimization, gave me deep expertise in cell culture, molecular biology, and translational research.
Now I'm pursuing my PhD in Oncology and Cancer Biology at Nirma University under Prof Sarat Dalai in the Immunology Lab. My research focuses on IL-12-based cytokine immunotherapy for cancer, exploring how engineered cytokines can reprogram the tumor microenvironment. I also served as a Senior Research Fellow with the Gujarat State Biotechnology Mission, and I've completed my pre-synopsis, bringing me closer to the finish line.
When I'm not in the lab, you'll find me at conferences sharing my work, reading the latest immuno-oncology literature, or mentoring students who are just beginning their research journey.
For the full career details, check out my LinkedIn.
I believe science grows through sharing. Here are some of the conferences where I've presented my work on cytokine immunotherapy and cancer biology.
Presented a poster on cytokine-based immunotherapy approaches targeting the tumor microenvironment, covering signaling, metabolism, imaging, and therapeutic targets.
View conference details →3 publications, 348 reads, and 8 citations. View all on ResearchGate.
A review of interleukin signaling in cancer biology and its therapeutic applications. Published in the World Journal of Biology Pharmacy and Health Sciences, 2024.
Read on ResearchGate → COVID-19A book chapter in "COVID-19: Diagnosis and Management, Part II" covering vaccine development strategies and approaches. Published June 2021.
Read on ResearchGate → DiagnosticsEvaluating liposome-based diagnostic approaches for TB detection. Published in Expert Review of Molecular Diagnostics, April 2020.
Read on ResearchGate →
Selected by the Gujarat State Biotechnology Mission to advance cytokine immunotherapy research in oncology, with dedicated funding for IL-12-based cancer studies.
Pursuing doctoral research at Nirma University under Prof Sarat Dalai in the Immunology Lab. Pre-synopsis completed, focusing on IL-12 cytokine immunotherapy.
Presented research at the 9th International Conference on Tumor Microenvironment and Cellular Stress in Kalamata, Greece.
3+ years developing novel biologics at India's largest pharma company. Developed a clone for aflibercept and worked on bevacizumab, IL-23, and GLP-2 projects.
Graduated with an A+ grade from Nirma University, building a strong foundation in microbiology, protein purification, and molecular biology.
Completed B.S. at Pramukhswami Medical College, Karamsad with an A grade, specializing in microbiology and biochemistry.
Science keeps me busy, but animals keep me grounded. Meet Charlie, Kitlu, and every furry friend in between.
Whether you want to discuss immuno-oncology research, potential collaborations, or just say hello, I'd love to hear from you.